한국 폐경 여성에서 호르몬치료 전후 Leptin계, 골의 생화학적 인자, 골밀도 사이의 연관성
The Association among Serum Leptin System, Bone Biochemical Markers and Bone Mineral Density Before and After Hormone Therapy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: To investigate the relationships between serum leptin, soluble leptin receptor (sLR) and bone mineral density (BMD) and bone biochemical markers and to evaluate association among these factors after hormone therapy (HT) in postmenopausal Korean women. Methods: Serum leptin, sLR, biochemical markers, osteoprotegerin (OPG) and soluble receptor activator of NF-kB ligand (sRANKL) were measured by enzyme linked immunosorbent assay in 159 postmenopausal Korean women. The BMD at the lumbar spine (LS) and femoral neck (FN) was determined by dual energy X-ray absorptiometry, and changes of these factors were also measured in 70 postmenopausal women receiving HT. Results: After adjustment for age and year since menopause, body mass index (BMI) was found to be significantly correlated with leptin (r=0.42, P<0.0001), sLR (r=-0.24, P<0.005), free leptin index (FLI, r=0.47, P<0.0001) and serum OPG was also correlated with serum leptin (r=-0.24, P<0.005) or sLR (r=-0.16, P<0.05). Serum leptin levels and FLI in obese women (BMI>25 kg/m2) were significantly higher than those in women with normal weight, whereas sLR levels were lower in the former women than in the latter women. After HT, serum leptin levels (P<0.005) and FLI (P<0.05) decreased significantly and decreased serum sLR levels (P<0.05) was found only in obese women. The percent changes in BMD at FN after HT were negatively correlated with the changes of sLR after HT. Conclusions: Circulating leptin system is not associated with BMD but BMI. Leptin and FLI decrease after HT and the changes of sLR reflects changes in BMD at FN after HT.
Abstract
Objectives: To investigate the relationships between serum leptin, soluble leptin receptor (sLR) and bone mineral density (BMD) and bone biochemical markers and to evaluate association among these factors after hormone therapy (HT) in postmenopausal Korean women. Methods: Serum leptin, sLR, biochemical markers, osteoprotegerin (OPG) and soluble receptor activator of NF-kB ligand (sRANKL) were measured by enzyme linked immunosorbent assay in 159 postmenopausal Korean women. The BMD at the lumbar spine (LS) and femoral neck (FN) was determined by dual energy X-ray absorptiometry, and changes of these factors were also measured in 70 postmenopausal women receiving HT. Results: After adjustment for age and year since menopause, body mass index (BMI) was found to be significantly correlated with leptin (r=0.42, P<0.0001), sLR (r=-0.24, P<0.005), free leptin index (FLI, r=0.47, P<0.0001) and serum OPG was also correlated with serum leptin (r=-0.24, P<0.005) or sLR (r=-0.16, P<0.05). Serum leptin levels and FLI in obese women (BMI>25 kg/m2) were significantly higher than those in women with normal weight, whereas sLR levels were lower in the former women than in the latter women. After HT, serum leptin levels (P<0.005) and FLI (P<0.05) decreased significantly and decreased serum sLR levels (P<0.05) was found only in obese women. The percent changes in BMD at FN after HT were negatively correlated with the changes of sLR after HT. Conclusions: Circulating leptin system is not associated with BMD but BMI. Leptin and FLI decrease after HT and the changes of sLR reflects changes in BMD at FN after HT.
참고문헌 (45)
- Legiran S, "Bone mass regulation of leptin and postmenopausal osteoporosis with obesity", Clin Cases Miner Bone Metab, 9, pp.145~149 (2012)
- Petzel M, "Action of leptin on bone and its relationship to menopause", Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 151, pp.195~199 (2007)
- Reid IR, "Relationships between fat and bone", Osteoporos Int, 19, pp.595~606 (2008)
- Di Carlo C, "Longitudinal evaluation of serum leptin and bone mineral density in early postmenopausal women", Menopause, 14, pp.450~454 (2007)
- Jen KL, "The relationship between blood leptin level and bone density is specific to ethnicity and menopausal status", J Lab Clin Med, 146, pp.18~24 (2005)
- Sherk VD, "Leptin, fat mass, and bone mineral density in healthy pre- and postmenopausal women", J Clin Densitom, 14, pp.321~325 (2011)
- Szalay F, "Serum leptin, soluble leptin receptor, free leptin index and bone mineral density in patients with primary biliary cirrhosis", Eur J Gastroenterol Hepatol, 17, pp.923~928 (2005)
- Thomas T, "Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women", Bone, 29, pp.114~120 (2001)
- Weiss LA, "Leptin predicts BMD and bone resorption in older women but not older men: the Rancho Bernardo study", J Bone Miner Res, 21, pp.758~764 (2006)
- Yamauchi M, "Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women", Clin Endocrinol (Oxf), 55, pp.341~347 (2001)
- Biver E, "Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and metaanalysis", J Clin Endocrinol Metab, 96, pp.2703~2713 (2011)
- Dennison EM, "Plasma leptin concentration and change in bone density among elderly men and women: the Hertfordshire Cohort Study", Calcif Tissue Int, 74, pp.401~406 (2004)
- Iwamoto J, "Serum leptin concentration positively correlates with body weight and total fat mass in postmenopausal Japanese women with osteoarthritis of the knee", Arthritis, 2011, pp.580632~ (2011)
- Jurimae J, "The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women", J Bone Miner Metab, 26, pp.618~623 (2008)
- Odabasi E, "Plasma leptin concentrations in postmenopausal women with osteoporosis", Eur J Endocrinol, 142, pp.170~173 (2000)
- Oguz S, "Is leptin a significant predictor of bone mineral density in postmenopausal Turkish women?", Rheumatol Int, 29, pp.393~396 (2009)
- Pasco JA, "Serum leptin levels are associated with bone mass in nonobese women", J Clin Endocrinol Metab, 86, pp.1884~1887 (2001)
- Ruhl CE, "Relationship of serum leptin concentration with bone mineral density in the United States population", J Bone Miner Res, 17, pp.1896~1903 (2002)
- Sahin G, "Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women", Rheumatol Int, 23, pp.87~91 (2003)
- Scariano JK, "Serum leptin levels, bone mineral density and osteoblast alkaline phosphatase activity in elderly men and women", Mech Ageing Dev, 124, pp.281~286 (2003)
- Shaarawy M, "Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis", Fertil Steril, 79, pp.919~924 (2003)
- Shabat S, "Serum leptin level in geriatric patients with hip fractures: possible correlation to biochemical parameters of bone remodeling", Arch Gerontol Geriatr, 48, pp.250~253 (2009)
- Gambacciani M, "Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy", Maturitas, 39, pp.125~132 (2001)
- Haarbo J, "Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause", Metabolism, 40, pp.1323~1326 (1991)
- Hadji P, "The influence of hormone replacement therapy (HRT) on serum leptin concentration in postmenopausal women", Maturitas, 37, pp.105~111 (2000)
- Lambrinoudaki IV, "Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women", Maturitas, 48, pp.107~113 (2004)
- Panidis DK, "The influence of tibolone upon serum leptin levels in postmenopausal women", Eur J Obstet Gynecol Reprod Biol, 96, pp.85~87 (2001)
- Machinal-Quelin F, "Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue", Endocrine, 18, pp.179~184 (2002)
- Castelo-Branco C, "Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study", Fertil Steril, 88, pp.383~389 (2007)
- Dedeoglu EN, "Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women", Fertil Steril, 91, pp.425~431 (2009)
- Elbers JM, "Effects of administration of 17beta-oestradiol on serum leptin levels in healthy postmenopausal women", Clin Endocrinol (Oxf), 51, pp.449~454 (1999)
- Konukoglu D, "Plasma leptin levels in obese and non-obese postmenopausal women before and after hormone replacement therapy", Maturitas, 36, pp.203~207 (2000)
- Roux C, "Serum leptin as a determinant of bone resorption in healthy postmenopausal women", Bone, 33, pp.847~852 (2003)
- Bednarek-Tupikowska G, "Serum leptin concentrations in preand postmenopausal women on sex hormone therapy", Gynecol Endocrinol, 22, pp.207~212 (2006)
- Cagnacci A, "Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: a double-blind, placebocontrolled study", Menopause, 9, pp.65~71 (2002)
- Nar A, "Effects of bilateral ovariectomy and estrogen replacement therapy on serum leptin, sex hormone binding globulin and insulin like growth factor-I levels", Gynecol Endocrinol, 25, pp.773~778 (2009)
- Petzel M, "The influence of estradiole and tibolone administration on leptin levels in women with surgically induced menopause", Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 152, pp.101~105 (2008)
- Di Carlo C, "Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women", Menopause, 14, pp.38~44 (2007)
- Lambrinoudaki IV, "Circulating leptin and ghrelin are differentially influenced by estrogen", progestin therapy and raloxifene, 2008, pp.59, 62~71
- Yuksel H, "Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition", Gynecol Endocrinol, 22, pp.381~387 (2006)
- Kim JGC, "H. Gynecologic Endocrinology" (2012), Koonja Publishing Company
- Kanis JA, "The diagnosis of osteoporosis", J Bone Miner Res, 9, pp.1137~1141 (1994)
- Filip R, "Bone mineral density and bone turnover in relation to serum leptin, alphaketoglutarate and sex steroids in overweight and obese postmenopausal women", Clin Endocrinol (Oxf), 70, pp.214~220 (2009)
- Licinio J, "Human leptin levels are pulsatile and inversely related to pituitary-adrenal function", Nat Med, 3, pp.575~579 (1997)
- Jurimae J, "Adipocytokine and ghrelin levels in relation to bone mineral density in physically active older women: longitudinal associations", Eur J Endocrinol, 160, pp.381~385 (2009)
